Form S-1 Sonnet BioTherapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Sonnet BioTherapeutics (SONN) Files for Share and Warrant Offering
October 28, 2024 9:07 AM EDTSonnet BioTherapeutics (NASDAQ: SONN) has filed the following:
We are offering shares of our common stock and common warrants to purchase an aggregate of shares of our common stock, par value $0.0001 per share (and the shares of common stock that are issuable from time to time upon exercise of the common warrants), at an assumed combined public offering price of $ , which is the last reported sale price of our common stock on , 2024. We are also offering to certain purchasers whose purchase of shares of common stock in this offering would otherwise result in... More
